Ultevursen
Based on 1 Customer Validation
Ultevursen (QR-421a) is a splice-modulating antisense oligonucleotide targeting exon 13 of the USH2A gene, which restores the functional expression of Usherin protein by inducing exon skipping. Ultevursen binds to USH2A pre-mRNA and modulates the splicing process to specifically skip exon 13 carrying the pathogenic mutation c.2299delG, generating an in-frame transcript and a truncated yet functionally normal protein. Ultevursen exhibits concentration-dependent exon skipping activity in human cells and retinal organoid models, and restores Usherin expression and retinal function in zebrafish and gene-edited mouse models. Ultevursen can be used for related research on type 2 Usher syndrome and non-syndromic retinitis pigmentosa.
For research use only. We do not sell to patients.
- Purity: 94.24%
- CAS No.: 2642382-41-8
- Formula: C273H391N81O144P20S20
- Molecular Weight:8372.24
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Usherin[1]
Ultevursen induces concentration-dependent USH2A exon 13 skipping in WERI-Rb1 cells[1].
Ultevursen induces concentration-dependent USH2A exon 13 skipping in patient-derived iPSC-derived photoreceptor progenitor cells[1].
Ultevursen (QR-421a) (50 ng; 3 days) delivered as a U7 snRNA skipper induces USH2A exon 13 skipping in stable HEK293T USH2A-eGFP reporter cells, leading to detectable eGFP expression[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Ultevursen associated AAV-U7 dual skipper (1 μL viral vector suspension; intratympanic + utricle microinjection; P1-P2 neonatal Ush2a KO-1/KO-1 mice; 16 weeks in vivo incubation period) achieves robust hair cell transduction and mediates sustained Ush2a exon skipping within mouse inner ear tissue[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Neonatal Ush2a KO-1/KO-2 WT/C57BL6 (P1-P2, both male and female) received intratympanic combined utricle microinjection of Ultevursen (QR-421a) associated AAV-U7 dual skipper (1 μL viral suspension per mouse)[2]
-
Dosage:1 μL viral suspension
-
Administration:Intratympanic + utricle microinjection; single administration; harvested after 16 weeks of in vivo incubation
-
Result:Achieved robust transduction of cochlear hair cells in mouse inner ear tissues.
Immunofluorescence staining showing stable Ush2a exon skipping effect and recovered usherin protein expression within inner ear hair cells.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 2642382-41-8
-
Appearance Solid
-
Molecular Weight 8372.24
-
Formula C273H391N81O144P20S20
-
Color White to off-white
-
SMILES
[Ultevursen]
-
Synonyms
QR-421a
-
Sequence
RNA, (P-thio)[2′-O-(2-methoxyethyl)](A-G-m5C-m5U-m5U-m5C-G-G-A-G-A-A-A-m5U-m5U-m5U-A-A-A-m5U-m5C)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2242 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Ultevursen
- 2642382-41-8
- QR-421a
- Nucleoside Antimetabolite/Analog
- DNA/RNA Synthesis
- iPSC-derived photoreceptor progenitor cells
- usherin protein
- usher syndrome type 2
- usher syndrome type 2a
- HEK293T USH2A-eGFP reporter cells
- USH2A exon 13
- USH2A c.2299delG
- WERI-Rb1 cells
- USH2A pre-mRNA
- non-syndromic retinitis pigmentosa
- Inhibitor
- inhibitor
- inhibit